{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:05:35Z","timestamp":1792901135894,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/PURSE\/2022\/143"],"award-info":[{"award-number":["SR\/PURSE\/2022\/143"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/CS-I\/2020\/152"],"award-info":[{"award-number":["SR\/FST\/CS-I\/2020\/152"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008812","name":"Defence Science and Technology Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008812","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["02(0399)\/21\/EMR-II"],"award-info":[{"award-number":["02(0399)\/21\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bmcl.2026.130681","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:08:42Z","timestamp":1777993722000},"page":"130681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development of isoxazole tethered 1,2,3-triazoles and sulphonamide derivatives as potent anti-bacterial and anti-cancer agents"],"prefix":"10.1016","volume":"138","author":[{"given":"Priyanuj Krishnann","family":"Hazarika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeb","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajit","family":"Mahanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhrubajyoti","family":"Gogoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babulal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diganta","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bmcl.2026.130681_bb0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/1871526523666230725103902","article-title":"An overview of the global alarming increase of multiple drug resistant: a major challenge in clinical diagnosis","volume":"24","author":"Alara","year":"2024","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.bmcl.2026.130681_bb0010","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.2147\/IDR.S530557","article-title":"Antimicrobial resistance: a rising global threat to public health","volume":"18","author":"Patra","year":"2025","journal-title":"Infect Drug Resist"},{"issue":"10459","key":"10.1016\/j.bmcl.2026.130681_bb0015","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130681_bb0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/ph18030402","article-title":"Combating antibiotic resistance: mechanisms, multidrug-resistant pathogens, and novel therapeutic approaches: an updated review","volume":"18","author":"Elshobary","year":"2025","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130681_bb0025","first-page":"1731","article-title":"Contributions of \u03b2-lactamase substrate specificity and outer membrane permeability to the antibiotic sheltering of \u03b2-lactam-susceptible bacteria","volume":"6","author":"Mora-Ochomogo","year":"2025","journal-title":"bioRxiv"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130681_bb0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.tim.2021.11.002","article-title":"Targeting bacterial outer-membrane remodelling to impact antimicrobial drug resistance","volume":"30","author":"Rosas","year":"2022","journal-title":"Trends Microbiol"},{"issue":"13","key":"10.1016\/j.bmcl.2026.130681_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4254\/wjh.v8.i13.573","article-title":"Hepatocellular carcinoma and the risk of occupational exposure","volume":"8","author":"Rapisarda","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.bmcl.2026.130681_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12935-018-0538-7","article-title":"Resistance: a major hindrance to chemotherapy in hepatocellular carcinoma: an insight","volume":"18","author":"Lohitesh","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130681_bb0045","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.bmc.2018.05.013","article-title":"Recent progress of isoxazole in medicinal chemistry","volume":"26","author":"Zhu","year":"2018","journal-title":"Bioorg Med Chem"},{"issue":"12","key":"10.1016\/j.bmcl.2026.130681_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101877","article-title":"Isoxazole analogues of dibenzazepine as possible leads against ulcers and skin disease: in vitro and in silico exploration","volume":"31","author":"Khan","year":"2023","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.bmcl.2026.130681_bb0055","doi-asserted-by":"crossref","unstructured":"Nauta KM, Ho TD, Ellermeier CD. The penicillin-binding protein PbpP is a sensor of \u03b2-lactams and is required for activation of the extracytoplasmic function \u03c3 factor \u03c3^P in Bacillus thuringiensis. mBio 2021;12(2): e001128\u201321.","DOI":"10.1128\/mBio.00179-21"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130681_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s42004-025-01801-x","article-title":"Binding mode of isoxazolyl penicillins to a class-a \u03b2-lactamase at ambient conditions","volume":"8","author":"Gore","year":"2025","journal-title":"Commun Chem"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130681_bb0065","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.2174\/1871520622666220412133112","article-title":"Design and development of triazole derivatives as prospective anticancer agents: a review","volume":"22","author":"Sachdeva","year":"2022","journal-title":"Anti Cancer Agents Med Chem"},{"key":"10.1016\/j.bmcl.2026.130681_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103933","article-title":"Design, synthesis and antitrypanosomal activity of heteroaryl-based 1,2,4-triazole and 1,3,4-oxadiazole derivatives","volume":"100","author":"Shaykoon","year":"2020","journal-title":"Bioorg Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130681_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13065-024-01205-3","article-title":"Synthesis and antitumor activity of dolutegravir derivatives bearing 1,2,3-triazole moieties","volume":"18","author":"Hou","year":"2024","journal-title":"BMC Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130681_bb0080","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3762\/bjoc.7.79","article-title":"Advances in synthetic approach to and antifungal activity of triazoles","volume":"7","author":"Shalini","year":"2011","journal-title":"Beilstein J Org Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130681_bb0085","doi-asserted-by":"crossref","first-page":"2000163","DOI":"10.1002\/ardp.202000163","article-title":"1,2,3-triazole hybrids with anti-HIV-1 activity","volume":"354","author":"Feng","year":"2021","journal-title":"Arch Pharm (Weinheim)"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130681_bb0090","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1039\/C4MD00127C","article-title":"Anti-bacterial glycosyl triazoles\u2014identification of an N-acetylglucosamine derivative with bacteriostatic activity against Bacillus","volume":"5","author":"Kuhn","year":"2014","journal-title":"MedChemComm"},{"issue":"17","key":"10.1016\/j.bmcl.2026.130681_bb0095","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.bmcl.2012.07.064","article-title":"Design, synthesis and evaluation of clinafloxacin\u2013triazole hybrids as a new class of antibacterial and antifungal agents","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2026.130681_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127144","article-title":"Biofilm inhibition and DNA binding studies of isoxazole-triazole conjugates in the development of effective anti-bacterial agents","volume":"1201","author":"Habib","year":"2020","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2026.130681_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2020.100629","article-title":"Synthesis and antibacterial activity of novel cinnoline\u2013isoxazole derivatives","volume":"31","author":"Bommagani","year":"2021","journal-title":"Chem Data Collect"},{"key":"10.1016\/j.bmcl.2026.130681_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138105","article-title":"Design, synthesis, and biological evaluation of eugenol-isoxazoline hybrid derivatives as potential anti-leishmanial agents","volume":"1308","author":"Rani","year":"2024","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmcl.2026.130681_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.107938","article-title":"Synthesis, biological evaluation, and molecular modelling of novel quinoxaline\u2013isoxazole hybrid as anti-hyperglycemic","volume":"106","author":"Phongphane","year":"2023","journal-title":"Comput Biol Chem"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130681_bb0120","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00044-019-02363-z","article-title":"Synthesis and in vitro evaluation of substituted tetrahydroquinoline\u2013isoxazole hybrids as anticancer agents","volume":"28","author":"G\u00fciza","year":"2019","journal-title":"Med Chem Res"},{"issue":"39","key":"10.1016\/j.bmcl.2026.130681_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202500575","article-title":"Sustainable synthesis of isoxazoles and isoxazolines directly from aldehydes via one-pot metal-free approach using a reusable ionic liquid [C8DABCO][OH] at room temperature","volume":"28","author":"Hazarika","year":"2025","journal-title":"Eur J Org Chem"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130681_bb0130","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective \u201cligation\u201d of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angew Chem Int Ed"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130681_bb0135","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1039\/D4SU00114A","article-title":"Sustainable and efficient synthesis of 1,4-disubstituted and N-unsubstituted 1,2,3-triazoles using reusable ZnO\u2013CTAB nanocrystals","volume":"2","author":"Hazarika","year":"2024","journal-title":"RSC Sustainability"},{"key":"10.1016\/j.bmcl.2026.130681_bb0140","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.msec.2015.12.078","article-title":"Amoxicillin-functionalized gold nanoparticles revert MRSA resistance","volume":"61","author":"Kalita","year":"2016","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.bmcl.2026.130681_bb0145","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41598-018-22736-5","article-title":"Functionalization of \u03b2-lactam antibiotic on lysozyme-capped gold nanoclusters retrogress MRSA and its persisters following awakening","volume":"8","author":"Kalita","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2026.130681_bb0150","series-title":"Performance standards for antimicrobial susceptibility testing; CLSI Supplement M100","author":"Clinical and laboratory standards institute (CLSI)","year":"2018"},{"key":"10.1016\/j.bmcl.2026.130681_bb0155","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard M07; CLSI: Wayne, PA, USA, 2020."},{"key":"10.1016\/j.bmcl.2026.130681_bb0160","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1021\/acsinfecdis.2c00193","article-title":"Synergy by perturbing the gram-negative outer membrane: opening the door for gram-positive-specific antibiotics","volume":"8","author":"Wesseling","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2026.130681_bb0165","article-title":"Antibacterial activities of sulfonyl- or sulfonamide-containing heterocyclic derivatives and their structure\u2013activity relationship studies: a critical review","volume":"105","author":"Verma","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2026.130681_bb0170","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/17460913.2025.2536375","article-title":"Resistance in gram-negative bacilli: the emergence of RND efflux pumps","volume":"20","author":"Agreles","year":"2025","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bmcl.2026.130681_bb0175","series-title":"ISO 10993-5: Biological Evaluation of Medical Devices\u2014Part 5: Tests for In Vitro Cytotoxicity","author":"International Organization for Standardization","year":"2009"},{"key":"10.1016\/j.bmcl.2026.130681_bb0180","first-page":"1","article-title":"In vitro cytotoxicity and cell viability assays: principles, advantages, and limitations","volume":"44","author":"Aslant\u00fcrk","year":"2018","journal-title":"Gen Appl Plant Physiol"},{"key":"10.1016\/j.bmcl.2026.130681_bb0185","first-page":"123","article-title":"Transferrin\u2013copper nanocluster\u2013doxorubicin nanoparticles as targeted theranostic cancer nanodrug","volume":"9","author":"Goswami","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bmcl.2026.130681_bb0190","series-title":"Assay Guidance Manual; Eli Lilly & Company and the National Center for Advancing Translational Sciences: Bethesda, MD, USA","article-title":"Cell viability assays","author":"Riss","year":"2016"},{"key":"10.1016\/j.bmcl.2026.130681_bb0195","article-title":"Analysis of cell viability by the lactate dehydrogenase assay","author":"Kumar","year":"2018","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.bmcl.2026.130681_bb0200","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130681_bb0205","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130681_bb0210","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.1199","article-title":"Target identification and mechanism of action in chemical biology and drug discovery","volume":"9","author":"Schenone","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"16","key":"10.1016\/j.bmcl.2026.130681_bb0215","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1016\/j.bmcl.2017.07.008","article-title":"Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents","volume":"27","author":"Ali","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"issue":"suppl_2","key":"10.1016\/j.bmcl.2026.130681_bb0220","doi-asserted-by":"crossref","first-page":"W609","DOI":"10.1093\/nar\/gkq300","article-title":"PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach","volume":"38","author":"Liu","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.bmcl.2026.130681_bb0225","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/febs.16645","article-title":"Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from mycobacterium tuberculosis","volume":"290","author":"Barelier","year":"2023","journal-title":"FEBS J"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130681_bb0230","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jmb.2007.01.073","article-title":"A novel two-domain architecture within the amino acid kinase enzyme family revealed by the crystal structure of Escherichia coli glutamate 5-kinase","volume":"367","author":"Marco-Mar\u00edn","year":"2007","journal-title":"J Mol Biol"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130681_bb0235","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.chembiol.2019.05.003","article-title":"Quinoline derivatives kill mycobacterium tuberculosis by activating glutamate kinase","volume":"26","author":"Makafe","year":"2019","journal-title":"Cell Chem Biol"},{"issue":"11","key":"10.1016\/j.bmcl.2026.130681_bb0240","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1107\/S0907444904023972","article-title":"Glutamate-5-kinase from Escherichia coli: gene cloning, overexpression, purification and crystallization of the recombinant enzyme and preliminary X-ray studies","volume":"60","author":"P\u00e9rez-Arellano","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130681_bb0245","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/febs.14511","article-title":"Characterisation of a putative glutamate 5-kinase from leishmania donovani","volume":"285","author":"Sienkiewicz","year":"2018","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130681_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01465-21","article-title":"Decreased methylenetetrahydrofolate reductase activity leads to increased sensitivity to Para-aminosalicylic acid in mycobacterium tuberculosis","volume":"66","author":"Yu","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130681_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035973","article-title":"Assessment of Pseudomonas aeruginosa N5,N10-methylenetetrahydrofolate dehydrogenase\u2013cyclohydrolase as a potential antibacterial drug target","volume":"7","author":"Eadsforth","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130681_bb0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1107\/S1744309107065931","article-title":"Structure of HsaD, a steroid-degrading hydrolase, from mycobacterium tuberculosis","volume":"64","author":"Lack","year":"2008","journal-title":"Acta Crystallogr F Struct Biol Cryst Commun"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130681_bb0265","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/bph.13810","article-title":"Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach","volume":"174","author":"Ryan","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130681_bb0270","first-page":"1","article-title":"Recent progress and structural insights of potential Hsp90 inhibitors as anticancer agents","author":"Singh","year":"2025","journal-title":"Mol Divers"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:20:19Z","timestamp":1783142419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S0960894X26001484"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130681","relation":{"is-supplemented-by":[{"id-type":"uri","id":"https:\/\/www.ccdc.cam.ac.uk\/mystructures\/structuredetails\/fedeeffd-fe04-f111-96dd-00505695f620","asserted-by":"subject"}]},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of isoxazole tethered 1,2,3-triazoles and sulphonamide derivatives as potent anti-bacterial and anti-cancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130681"}}